Discover funding opportunities for healthcare innovation, offering valuable support for collaborative projects. Explore our list below, regularly updated with new options. Connect with us at fundingsupport@lshubwales.com for guidance, bid writing assistance, and finding the perfect match for your innovation.
The Patient Care Pioneer Award provides funding specifically for patient-focused applied research which has direct relevance to leukaemia and/or related diseases. The funding supports innovative patient-centred projects that aim to explore new practical approaches to improve treatment/post-treatment, care, and quality of life for individuals living with leukaemia.
Funding to enhance timely access to care through the development, clinical validation and/or real-world evidence generation of transformative and disruptive technologies.
The fellowships scheme provides support for researchers wishing to undertake independent research and gain leadership skills. They support the transition of early stage researchers to fully independent research leaders.
Grants available to academic researchers working to advance new gene therapy technologies, ranging from preclinical research through to early clinical studies, with additional funding available to successful projects to enable them to use the manufacturing capabilities of the Innovation Hubs for Gene Therapies.
The Cancer Research Wales Brain Tumour Research Initiative (BATRI) has been set up to build a critical mass of research into brain and other central nervous system (CNS) tumours in Wales.
The Eve Appeal runs the Research Fellowships scheme as a way of investing in early and mid-career researchers with potential, and developing effective methods of prediction, prevention, diagnosis and early detection of gynaecological cancers. The aim is to support researchers to gather data and strengthen their bids for longer-term substantive funding and to emerge as research leaders.
Small grants for UK researchers and teams carrying out early stage innovation on the prevention of gynaecological cancers (womb, ovarian, cervical, vulval and vaginal).
Early detection & prevention: spotting the biological signatures of arthritis early to maximise the opportunities for timely intervention and preventing it from getting worse.
Targeted treatments: taking the guesswork out of treatment by increasing effective, reliable and timely drug and non-drug solutions to reduce, manage or cure disease.
Funding for novel and innovative research focused on reducing the time it takes women to get effective treatment for heavy menstrual bleeding from five years to five months.
THRIVE aims to accelerate the translation of healthcare innovations tackling health inequalities from bench to bed, speed up patient benefit and concurrently expand the entrepreneurial mindset of researchers and clinicians.
Funding for new researcher and clinician-led THRIVE (Translate Healthcare Research through InnoVation and Entrepreneurship) funding and training opportunity.
Funding from the NIH to support research teams seeking to translate basic scientific findings into therapeutic interventions for patients, and to increase understanding of important disease processes.
AI for health: future predictive research for a healthier population, covering novel AI, automation and data science techniques to creating a healthier state. This includes advanced diagnostics, visualisation of invisible disease lesions and prediction and prevention of lifestyle-related diseases, frailty and early detection of cognitive decline.
The Huo Family Foundation invites applications for its Special Projects Grants, supporting long-term, multidisciplinary research into the effects of digital technology on children and young people. These larger grants are open to researchers at all career stages, encouraging collaboration across diverse fields to address complex questions. Projects should explore how digital technology usage and exposure impact brain development and function (including physiological responses), social behaviour and interactions, and mental health.
Funding to support collaborative research and development of medical devices, in vitro diagnostic devices and high-impact patient-focused digital health technologies for use in the NHS or social care system in the UK.
The UKRI Proof of Concept funding supports the early to mid-stage commercialisation of innovative technologies, products, or services developed from research at eligible UK institutions, including universities and research centres. It aims to bridge the gap between research and real-world application by validating commercially promising concepts. Funding can support various routes, such as licensing, spinouts, or social ventures. The goal is to de-risk ideas, attract further investment, and accelerate the translation of research into societal and economic impact through practical, scalable solutions.
This Funding Opportunity Announcement encourages applications that investigate the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem globally. Because of the high incidence and frequent tumour recurrence, bladder cancer exacts an outsized medical burden. While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression and malignancy of bladder cancer. Furthermore, understanding of the biological processes of the normal bladder at the molecular, cell and organ levels is limited. Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid understanding of bladder cancer biology and contribute to the future development of new interventions.
The 2025 call invites proposals addressing one of seven identified Grand Challenges: AI-human collaboration, cancer avoidance in high-risk groups, the dark proteome, unexplained mutational signatures, cancer–nervous system interactions, rewiring cancer cells, and tumour microenvironment dynamics. Projects must offer novel thinking and incorporate expertise not traditionally applied to cancer, with a clear trajectory toward prevention, diagnosis, or treatment.
Wellbeing of Women's Research Training Fellowships support individuals pursuing a career in academic medicine within obstetrics, gynaecology, or women’s reproductive health. Fellowships can fund basic science, clinical, or translational research, including feasibility studies and systematic reviews, that address clinical or patient needs and aim to improve health outcomes. Projects may be new or ongoing, but must include substantial training leading to a higher degree. All fellowships must be based at a UK research institution.
The MS Society Catalyst Award provides support over a maximum of 12 months for short-term, small-scale pilot or proof of concept research projects to explore innovative ideas in MS research. Projects should be hypothesis driven and may be 'high-risk, high-reward' in nature.
Apply for funding to undertake ambitious interdisciplinary research to tackle epidemic diseases of animals, humans or plants for a duration of up to five years.
Grants to support early career researchers in the UK undertaking translational or proof of concept research in any area of gastroenterology (including pancreatology and hepatology).
Funding available to UK organisations and educational establishments for the funding of capital infrastructure in the fields of science and medicine, health, education and the arts and humanities.
Doctoral funding programme for research institutions in the UK to host PhD research projects focusing on the molecular and cellular basis of retinal degeneration.
Projects should aim to develop new methodologies, frameworks, tools, or techniques that benefit health-related research. Proposals must align with Wellcome’s discovery research remit and can be single-discipline or multidisciplinary, spanning areas such as STEM, experimental medicine, clinical and allied health sciences, public health, humanities, and social sciences.
HIS offers research grants to support research projects in the field of healthcare-associated infections (HCAIs) and infection prevention and control in the UK or Ireland. The thematic focus is on translational research.
This award aims to accelerate and drive forward the development of novel drugs for the treatment of Parkinson's. The initiative should provide researchers with the opportunity to generate essential data and help bridge the gaps needed to get their projects/compounds ready to enter full scale drug discovery with an industry partner.
Fellowships are available for European and Japanese researchers from any discipline to carry out a research visit in either Japan or Europe, respectively.
This Funding Opportunity Announcement (FOA) supports discrete, well-defined projects in any area of cancer research using the National Institutes of Health R03 small grant mechanism. The National Institutes of Health R03 small grant mechanism supports discrete, well-defined projects that realistically can be completed in two years and that require limited levels of funding. Examples of the types of projects that the R03 grant mechanism include, but are not limited to, the following: Pilot or feasibility studies.Secondary analysis of existing data.Small, self-contained research projects.Development of research methodology.Development of new research technology.
This Notice of Funding Opportunity (NOFO) invites mechanistic research that aims to understand how and why expectancy effects occur in a cancer context, elucidate their role in cancer symptom management, and identify patients, symptoms, cancer sites and contexts in which expectancy effects can be leveraged to improve cancer outcomes. Expectancies are defined in this context as beliefs about future outcomes, including one's response to cancer or cancer treatment. Expectancies can be evoked by social, psychological, environmental and systemic factors. Expectancy effects are the cognitive, behavioural and biological outcomes caused by expectancies. Expectancy effects can be generated by expectancies held by patients, clinicians, family members, caregivers and/or dyadic/social networks.
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is inviting research projects that implement early phase (Phase 0, I and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of NCI's Division of Cancer Treatment and Diagnosis (DCTD) and Office of HIV and AIDS Malignancies (OHAM). The proposed project must involve at least one clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program, and/or the HIV and AIDS Malignancies Research Programs.
